Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data

AIMS: There has been a dramatic increase in hypoglycaemic agent expenditure. We assessed the variability in prescribing costs at the practice level and the relationship between expenditure and the proportion of patients achieving target glycaemic control. METHODS: We utilized national prescribing da...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Peter N., Siah, Qi Zhuang, Marei, Omar, McDade‐Kumar, Mia, Rachedi, Nasser, Bracchi, Robert, Boldero, Richard, Haines, Kath, Ali, Mohammed Alhadj, French, Robert, Dayan, Colin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research: Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545615/
https://www.ncbi.nlm.nih.gov/pubmed/35766972
http://dx.doi.org/10.1111/dme.14908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545615/
https://www.ncbi.nlm.nih.gov/pubmed/35766972
http://dx.doi.org/10.1111/dme.14908

Ejemplares similares